IBERE PHARMACEUTICALS Quarterly Return On Equity in % from Q3 2021 to Q3 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Ibere Pharmaceuticals quarterly/annual Return On Equity history and growth rate from Q3 2021 to Q3 2022.
  • Ibere Pharmaceuticals Return On Equity for the quarter ending September 30, 2022 was -82.9 %, a 533% decline year-over-year.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2022 -82.9 -69.8 -533% Jul 1, 2022 Sep 30, 2022
Q2 2022 -81 Apr 1, 2022 Jun 30, 2022
Q1 2022 -52.5 Jan 1, 2022 Mar 31, 2022
Q4 2021 -13.1 Oct 1, 2021 Dec 31, 2021
Q3 2021 -13.1 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.